PE20010623A1 - Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria - Google Patents

Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria

Info

Publication number
PE20010623A1
PE20010623A1 PE2000001005A PE0010052000A PE20010623A1 PE 20010623 A1 PE20010623 A1 PE 20010623A1 PE 2000001005 A PE2000001005 A PE 2000001005A PE 0010052000 A PE0010052000 A PE 0010052000A PE 20010623 A1 PE20010623 A1 PE 20010623A1
Authority
PE
Peru
Prior art keywords
tramadol
treatment
urinary
demetiltramadol
increased
Prior art date
Application number
PE2000001005A
Other languages
English (en)
Spanish (es)
Inventor
Elmar Josef Friderichs
Thomas Christoph
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19947747A external-priority patent/DE19947747A1/de
Priority claimed from DE20002943U external-priority patent/DE20002943U1/de
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20010623A1 publication Critical patent/PE20010623A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE2000001005A 1999-10-05 2000-09-25 Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria PE20010623A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947747A DE19947747A1 (de) 1999-10-05 1999-10-05 Verwendung von (+)-Tramadol, O-Demethyltramadol bzw. (+)-O-Demethyltramadol zur Therapie der Harninkontinenz
DE20002943U DE20002943U1 (de) 2000-02-21 2000-02-21 Arzneimittel enthaltend O-desmethyl-N-mono-desmethyl-tramadol

Publications (1)

Publication Number Publication Date
PE20010623A1 true PE20010623A1 (es) 2001-07-07

Family

ID=26055167

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001005A PE20010623A1 (es) 1999-10-05 2000-09-25 Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria

Country Status (13)

Country Link
US (1) US6660774B2 (https=)
EP (1) EP1217998B1 (https=)
JP (1) JP5477881B2 (https=)
AT (1) ATE368455T1 (https=)
AU (1) AU7907600A (https=)
CA (1) CA2386381A1 (https=)
DE (1) DE50014532D1 (https=)
ES (1) ES2291223T3 (https=)
HK (1) HK1047707A1 (https=)
HU (1) HUP0202776A2 (https=)
MX (1) MXPA02003491A (https=)
PE (1) PE20010623A1 (https=)
WO (1) WO2001024783A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
FR2815691B1 (fr) * 2000-10-20 2003-08-15 Valois Sa Bille de clapet
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
DE10224107A1 (de) * 2002-05-29 2003-12-11 Gruenenthal Gmbh Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz
DE10224624A1 (de) * 2002-05-30 2003-12-11 Gruenenthal Gmbh Metabolite und Prodrugs von 1-Dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
JP4059259B2 (ja) 2005-06-30 2008-03-12 ヤマハ株式会社 スピーカシステムおよびスピーカエンクロージャー
WO2007018234A1 (ja) * 2005-08-10 2007-02-15 Nippon Shinyaku Co., Ltd. 尿道内圧上昇作用剤
DK1940467T3 (da) 2005-09-09 2017-02-13 Paladin Labs Inc Lægemiddelsammensætning med langvarig frigivelse
CN101252932B (zh) 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
EP2281558A1 (en) * 2009-08-06 2011-02-09 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical compounds of O-Desmethyl-Tramadol and COX-inhibitors
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US11000488B2 (en) 2019-03-22 2021-05-11 Syntrix Biosystems Inc. Treating pain using desmetramadol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095523C (en) 1991-09-06 2004-06-22 Robert B. Raffa Composition comprising a tramadol material and acetaminophen and its use
AU657351B2 (en) 1991-09-06 1995-03-09 Mcneilab, Inc. Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
EP0969818B1 (en) * 1997-03-11 2004-09-08 Arakis Ltd. Dosage forms comprising separate portions of r- and s-enantiomers
DE19712398A1 (de) * 1997-03-25 1998-10-01 Gruenenthal Gmbh Orale Anwendung von (+)-0-Demethyltramadol als Schmerzmittel
EP1005861B1 (en) 1997-04-11 2005-06-29 Nippon Shinyaku Co., Ltd. Remedies for frequent urination and urinary incontinence
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles

Also Published As

Publication number Publication date
MXPA02003491A (es) 2002-08-20
EP1217998B1 (de) 2007-08-01
CA2386381A1 (en) 2001-04-12
ATE368455T1 (de) 2007-08-15
ES2291223T3 (es) 2008-03-01
WO2001024783A2 (de) 2001-04-12
JP5477881B2 (ja) 2014-04-23
US20030069314A1 (en) 2003-04-10
AU7907600A (en) 2001-05-10
HK1047707A1 (zh) 2003-03-07
WO2001024783A3 (de) 2002-02-28
EP1217998A2 (de) 2002-07-03
HUP0202776A2 (hu) 2003-02-28
US6660774B2 (en) 2003-12-09
DE50014532D1 (de) 2007-09-13
JP2003510350A (ja) 2003-03-18

Similar Documents

Publication Publication Date Title
PE20010623A1 (es) Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
UY27720A1 (es) Aroilpiridinonas monocíclicas,
MXPA04002702A (es) Forma de dosificacion para el tratamiento de diabetes mellitus.
CL2004001701A1 (es) Sal mono-isetionato de 6-acetil-8-ciclopentil-5-metil-2-(5-piperazub-1-il-piridin-2-ilamino)-8h-piro[2,3-dipirimidin-7-ona en sus formas cristalinas a, b y d; metodos de preparacion; composicion farmaceutica; y su uso para el tratamiento de cancer, a
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
EE04344B1 (et) Telmisartaani polümorfid, meetodid nende valmistamiseks ja nende kasutamine ravimi valmistamiseks
CU23367A3 (es) Formulación de moxifloxacino con sal común
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
CU23260B7 (es) PREPARADO FARMACéUTICO DE MOXIFLOXACINA
MXPA03004714A (es) Sales de una isotiazol-4-carboxamida y su uso como agentes de antihiperproliferacion.
ATE417608T1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
AU2001255241A1 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
AR047346A1 (es) Composicion farmaceutica de vinflunina para administracion parnteral, proceso de preparacion y uso de la misma
BR0308795A (pt) Amidas do ácido sulfamico
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
PT1294732E (pt) Compostos de rutenio (ii) para utilizacao na terapia do cancro
GEP20043231B (en) Resorcinol Composition
BR0213434A (pt) Método para evitar demência em um paciente, e, uso de rosuvastatina ou seu sal farmaceuticamente aceitável
UY26366A1 (es) Uso de (+)- tramadol, o demetiltramadol y/o (+) -o- demetiltramadol, o - desmetil-n-monodesmetil-tramadol, y/o (+) -o desmetil-n-monodesmetil-tramadol para la preparacion de un medicamento para el tratamiento de urgencia urinaria incrementada o incon
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
BRPI0407304A (pt) Agentes antibacterianos

Legal Events

Date Code Title Description
FC Refusal